Gene · 488
Papers3,333
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,333
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases. | J Pers Med | 2021 | 34945845 | PubTator, text mining | PubMed |
| Role of Store-Operated Ca2+ Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension. | Biomolecules | 2021 | 34944425 | PubTator, text mining | PubMed |
| Development of a 3-Dimensional Model to Study Right Heart Dysfunction in Pulmonary Arterial Hypertension: First Observations. | Cells | 2021 | 34944102 | PubTator, text mining | PubMed |
| Immuno-Metabolic Modulation of Liver Oncogenesis by the Tryptophan Metabolism. | Cells | 2021 | 34943977 | PubTator, text mining | PubMed |
| Differential Effects of 25-Hydroxyvitamin D3 versus 1α 25-Dihydroxyvitamin D3 on Adipose Tissue Browning in CKD-Associated Cachexia. | Cells | 2021 | 34943890 | PubTator, text mining | PubMed |
| Association Study of Genetic Variants in Calcium Signaling-Related Genes With Cardiovascular Diseases. | Front Cell Dev Biol | 2021 | 34912794 | PubTator, text mining | PubMed |
| The small molecule SERCA activator CDN1163 increases energy metabolism in human skeletal muscle cells. | Curr Res Pharmacol Drug Discov | 2021 | 34909682 | PubTator, text mining | PubMed |
| circATP2A2 promotes osteosarcoma progression by upregulating MYH9. | Open Med (Wars) | 2021 | 34901459 | PubTator, text mining | PubMed |
| Acute RyR1 Ca2+ leak enhances NADH-linked mitochondrial respiratory capacity. | Nat Commun | 2021 | 34893614 | PubTator, text mining | PubMed |
| N-Acetyl Cysteine, Selenium, and Ascorbic Acid Rescue Diabetic Cardiac Hypertrophy via Mitochondrial-Associated Redox Regulators. | Molecules | 2021 | 34885867 | PubTator, text mining | PubMed |
| Targeting Mediators of Inflammation in Heart Failure: A Short Synthesis of Experimental and Clinical Results. | Int J Mol Sci | 2021 | 34884857 | PubTator, text mining | PubMed |
| Zfhx3 Transcription Factor Represses the Expression of SCN5A Gene and Decreases Sodium Current Density (INa). | Int J Mol Sci | 2021 | 34884836 | PubTator, text mining | PubMed |
| Carfilzomib Treatment Causes Molecular and Functional Alterations of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. | J Am Heart Assoc | 2021 | 34873922 | PubTator, text mining | PubMed |
| MicroRNA-Related Strategies to Improve Cardiac Function in Heart Failure. | Front Cardiovasc Med | 2021 | 34869689 | PubTator, text mining | PubMed |
| Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients. | Front Immunol | 2021 | 34867990 | PubTator, text mining | PubMed |
| miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic Retinopathy. | Front Endocrinol (Lausanne) | 2021 | 34858342 | PubTator, text mining | PubMed |
| High Fasting Glycemia Predicts Impairment of Cardiac Autonomic Control in Adults With Type 2 Diabetes: A Case-Control Study. | Front Endocrinol (Lausanne) | 2021 | 34858333 | PubTator, text mining | PubMed |
| Expression of Genes and Proteins of the Sarcoplasmic Reticulum Са2+-Transport Systems in Cardiomyocytes in Concomitant Coronary Heart Disease and Type 2 Diabetes Mellitus. | Bull Exp Biol Med | 2021 | 34855078 | PubTator, text mining | PubMed |
| Nicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells. | Cell Death Dis | 2021 | 34845199 | PubTator, text mining | PubMed |
| Value of SERCA2a as a Biomarker for the Identification of Patients with Heart Failure Requiring Circulatory Support. | J Pers Med | 2021 | 34834474 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/488/papers?page=42